Thu 21 May 2020:
(Bloomberg) Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world.
Requests for export
Think your friends would be interested? Share this story!